• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    Instrumentation Innovations: A Review of Instrument Manufacturing

    The Total Package: Packaging and Sterilization for Orthopedics

    Helping Nature Take Its Course: A Biologics Breakdown

    Making the Grade: Orthopedic Materials Spotlight

    Mending Mishaps: A Trauma Technology Overview
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System

    Kaia Health Unveils Next-Gen Complete MSK Care Solutions

    First Implantation of CTL Amedica's Minimally Invasive Flex Tower

    NuVasive Nabs Simplify Medical for $150M

    SeaSpine Begins Limited Launch of WaveForm TA (TLIF Articulating) 3D-Printed Interbody
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System

    First Implantation of CTL Amedica's Minimally Invasive Flex Tower

    NuVasive Nabs Simplify Medical for $150M

    SeaSpine Begins Limited Launch of WaveForm TA (TLIF Articulating) 3D-Printed Interbody

    Nexus Spine Implants for Use in Spinal Surgeries Become Available
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Orthopedic Solutions from Man’s Best Friend

    The FDA’s Flip-Flop on Hyaluronic Acid

    HSS, Zimmer Biomet's Solution for the Episode of Orthopedic Care

    Rising to the Challenge: Q&A with AAOS Second VP Dr. Savoie

    Teleconferencing in the OR
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    ARCH Medical Solutions

    MedTorque Inc.

    Donatelle

    WuXi AppTec

    Tecomet
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    Medical Device Equivalence Requirements Strengthened under the EU MDR

    This column focuses on the directive under EU 2017/745 on medical devices (MDR), highlighting some of the changes in claiming and demonstrating equivalence.

    Medical Device Equivalence Requirements Strengthened under the EU MDR
    Cindy Boyer, Senior Manager, International Regulatory Affairs, MCRA LLC11.18.20
    The EU Medical Device Regulation (MDR) is officially known as Regulation (EU) 2017/745 of the European Parliament and of the Council of April 5, 2017.1 It amends Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009. It repeals Council Directives 90/385/EEC and 93/42/EEC. MDR consolidates two existing legal provisions and replaces both the current Medical Device Directive (93/42/EEC) and the Active Implantable Medical Device Directive (90/385/EEC).2

    Medtech companies must adopt the MDR for continued EU market access. Although the coronavirus pandemic prompted regulators to extend the deadline for EU MDR adoption by one year (now May 26, 2021), medical device manufacturers must be proactive and begin preparing now.

    As an adjunct to the actual regulation, MDCG 2020-5: Clinical Evaluation – Equivalence. A guide for manufacturers and notified bodies (April 2020),3 was published and endorsed by the Medical Device Coordination Group (MDCG), a governing body comprised of EU Member States representatives and chaired by a delegate of the European Commission. However, the MDCG document is not a Commission document and does not reflect the agency’s official position. MDCG 2020-5’s authors acknowledge the guidance document is not legally binding, but rather should be regarded as “best practice.”3

    This column focuses on the directive under EU 2017/745 on medical devices (MDR), highlighting some of the changes in claiming and demonstrating equivalence.

    At a glance, to claim equivalence under the MDR:
    • Implants and Class III devices must include an agreement to access technical documentation for the equivalent device. (If the device is made by a different manufacturer, this type of access to proprietary information will, most likely, not be available).
    • The technical criteria chosen to demonstrate equivalence must support the equivalence argument and critical performance specifications for the device under consideration. This should include product-specific standards or side-by-side testing of the equivalent device
    • To show equivalency to an existing CE marked product, a table must be created that compares the supporting technical, biological, and clinical characteristics of the two devices. The Notified Body will question any differences and their significance to safety and performance. For significant differences, a medical professional needs to provide formal justification.
    • Equivalency claims for products being initially CE Marked or sold in the EU need a solid justification to the Notified Body of how the data applies to an EU population This includes a thorough analysis of any safety and performance gaps related to the clinical performance.
    There are three main characteristics of an equivalent device used to support conformity with the General Safety and Performance requirements (GSPRs): Technical, Biological, and Clinical. A detailed discussion of each follows.

    Technical Characteristics: The MDR states devices are to be used under similar conditions of use, while MEDDEV 2.7/1 Rev. 4 requires devices be used under the same conditions of use1. “Conditions of use” encompasses environmental factors such as magnetic fields, temperature, moisture, and conditions during transport.

    Interpretation: The conditions of use must be similar enough where there is no clinically significant difference in device safety and performance.

    The MDR and MEDDEV 2.7/1 Rev. 4 have different examples/language describing similar specifications and properties. The listings are only examples and not exhaustive.

    The MDR specifically states that software algorithms must be similar and the similarities should be based on the software algorithms’ functional principle, clinical performance, and intended purpose.

    Equivalence does not have to be demonstrated for the software code. Software intended to for the configuration of a device (e.g. presentation on graphical user interface) and not related to a medicinal purpose (e.g. diagnostic, treatment, etc.) does not have to be similar.

    Biological Characteristics
    Under both the MDR and MEDDEV 2.7/1 Rev. 4, the subject and equivalent devices must use the same materials or substances. However, MEDDEV 2.7/1 Rev. 4 provides exceptions for devices that come in contact with intact skin, and minor device components.

    Interpretation: The exception outlined in MEDDEV 2.7/1 Rev. 4 to not use the same materials is not acceptable under the MDR.

    The MDR has additional text requiring similar release characteristics of substances to account for variability caused by processing, design, and use environment. For example, small changes in pH or oxidative stress can increase or decrease material release characteristics. It should be noted that properties and characteristics of the final device are to be considered.

    Additional MDR requirements cover:
    • Products composed of substances absorbed or locally dispersed in the body. Under Directive 2001/83/EC, the Notified Body must seek a scientific opinion from a competent authority or the European Medicines Agency (EMA)
    • Devices that include an ancillary medicinal substance (e.g., a drug-eluting stent). The medicinal substance, and any excipients/coatings, must be the same substance. The Notified Body is required to verify the usefulness of the substance and seek a scientific opinion from a competent authority or EMA.

    Clinical Characteristics
    The MDR requires the kind of user to be the same. The regulation defines “user” as any healthcare professional or lay person who uses a device; a “lay person” is identified as an individual with no formal education in a relevant healthcare field or medicinal discipline.

    Manufacturers must consider if the users are comparable. An example would be “professional use” vs. “home use.”

    The MDR does not explicitly state the device has to be used for the same medical indication, gender, and duration of use (MEDDEV 2.7/1 Rev. 4 does). The MDR language is more general, but defines the end user through different language.

    Demonstration of Equivalence
    The MDR requires scientific justifications for claiming there are no clinically significant differences between a device’s technical, biological, and clinical characteristics. Each equivalent device must be independently equivalent to the subject device. Different parts of different devices cannot be used to claim equivalence to the subject device. One exception to this rule are “device systems” that involve several stand-alone products. In those cases, stand-alone devices within a system may claim equivalence to another stand-alone device within other systems, provided the system devices do not affect the safety and performance of one another.

    Clinical Investigations
    Besides the demonstration of equivalence, the MDR has specific requirements to avoid conducting a clinical investigation. Implantable and Class III devices require a clinical investigation unless they have been designed by modifications.
    • Same manufacturer: The equivalent device must already be CE marked under the MDR or Directives 93/42/EEC or 90/385/EEC. The CE mark has to be current, and the Clinical Evaluation Report (CER) must be up-to-date with a favorable risk-benefit profile.
    • External manufacturer: There must be a contract in place allowing full access to technical documentation on an ongoing basis. The original CER of the equivalent device must be MDR-compliant (not certified under Directives 93/42/EEC or 90/385/EEC). A manufacturer can claim equivalence to a device certified with respect to the MDR or Directives 93/42/EEC or 90/385/EEC.
    Devices not CE marked can be considered for equivalence, provided:
    • The manufacturer has sufficient access to data
    • The equivalent device from an external manufacturer does not require contact between manufacturers for access to technical documentation
    • Clinical investigations were conducted according to international guidelines
    • Clinical data meets MDR requirements

    The Clinical Investigation Requirement for products without an Intended Medical Purpose (MDR Annex XVI) requires applicants to perform a clinical investigation unless existing data from an analogous device is justified. Analogous devices have a similar function and risk profile and are designed for a specific medical purpose. A clinical investigation would be needed for an equivalent product to a subject device with an aesthetic/non-medical purpose.

    In summary, manufacturers must be cautious when claiming and demonstrating equivalence under the MDR. They need to specify and justify the level of clinical evidence necessary to demonstrate conformity with the relevant GSPRs, identify all clinical data (favorable and unfavorable) for both the subject and equivalent device. Additionally, differences between the subject and equivalent device must be discussed.

    Similarly, manufacturers should avoid claiming equivalence if they cannot demonstrate sufficient levels of access to equivalent device data, and make claims to products without an intended medical purpose (listed in the MDR Annex XVI). Additionally, equivalence claims cannot be made for an ancillary medicinal substance as a “stand-alone” medicinal substance, or interchange claims to a non-ancillary medicinal substance if the subject device has an ancillary medicinal substance (and vice versa). 

    References
    1. bit.ly/odt201151
    2. bit.ly/odt201152
    3. bit.ly/odt201153


    Cindy Boyer is an accomplished healthcare professional with over 15 years in the spine and cardiovascular medical device research and development expertise. At MCRA, Cindy supports international regulatory strategy and submissions for clientele. She contributes to the development of technical and regulatory documents. Using her biological and healthcare background to assist with pre-clinical and clinical strategies, she effectively communicates these strategies to internal team members and clients.

    Related Columns

    • Striving to Attain a Gain on the Pain

      Striving to Attain a Gain on the Pain

      A growing number of orthopedic patients are wrestling with fear, perhaps fueled in part by variant virus strains believed to be more contagious.
      Michael Barbella, Managing Editor 02.08.21

    • Rethink Your Orthopedic ASC Strategy, Part 1

      Rethink Your Orthopedic ASC Strategy, Part 1

      ASCs have adopted a strategy to focus on predictable, low-risk procedures with lower complication rates in an out-of-hospital setting.
      Maria Shepherd, President and Founder, Medi-Vantage 02.08.21

    • Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic-Level Playing Field: How COVID-19 Made Space for Progress

      Pandemic restrictions may have diminished certain advantages large companies hold over small and mid-sized competitors.
      Dawn A. Lissy, Founder & President, Empirical 02.08.21


    • Tips for Reigniting Your MDR/IVDR Preparation

      Tips for Reigniting Your MDR/IVDR Preparation

      To get the MDR/IVDR preparation ball rolling again, here are four processes to help refocus on achieving compliance with the updated regulations.
      Nicolle Cannon, Founder and CEO, Cannon Quality Group LLC 02.08.21

    • Biologics
      An FDA Regulatory Perspective on Bone Grafts

      An FDA Regulatory Perspective on Bone Grafts

      There are various bone grafts with different composition, source, mechanical strength, and functional biological mechanisms.
      Mehdi Kazemzadeh-Narbat, Ph.D., Senior Associate, Regulatory Affairs, MCRA LLC 02.08.21

    • Packaging & Sterilization
      Building a More Transparent Healthcare Supply Chain with UDI

      Building a More Transparent Healthcare Supply Chain with UDI

      The FDA’s 2013 Unique Device Identification (UDI) Rule sets specific requirements for medical device labeling to improve traceability and patient safety.
      Beth Wells, Senior Director, Community Engagement, Healthcare, GS1 US 02.08.21


    • Stryker Strikes Back After Pandemic Slump

      Stryker Strikes Back After Pandemic Slump

      Late last year, Stryker announced it would snap up Wright Medical to fortify its position in the trauma and extremities markets.
      Sam Brusco, Associate Editor 11.18.20

    • Large Joint
      Obesity and the Impact on Hip and Knee Implants

      Obesity and the Impact on Hip and Knee Implants

      Obesity causes multiple health issues, and the COVID-19 pandemic is only adding to the problem.
      Maria Shepherd, President and Founder, Medi-Vantage 11.18.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.18.20


    • 13 Mistakes to Avoid in a 510k Submission

      13 Mistakes to Avoid in a 510k Submission

      The FDA 510(k) review process can broadly be divided into two steps—acceptance review and substantive review.
      Samradni Patil, Regulatory Consultant and Writer, Kolabtree 11.18.20

    • Contract Manufacturing
      A Supply Chain Strategy for Pandemic Survival

      A Supply Chain Strategy for Pandemic Survival

      Medical device supply chain managers will likely conclude that 2020 is a year best forgotten.
      Tony Freeman, President, A.S. Freeman Advisors LLC 11.18.20

    • Solid Footing During Shaky Times: Current Compliance Considerations

      Solid Footing During Shaky Times: Current Compliance Considerations

      The changes and challenges wrought by COVID-19 have significantly impacted the medtech industry.
      Bryan Brosseau, Founder and Principal Consultant, Brosseau Consulting LLC 11.18.20


    • A Wrinkle in the COVID-19 Financial Recovery

      A Wrinkle in the COVID-19 Financial Recovery

      A British Journal of Surgery study projected the global pandemic would postpone or outright cancel 6.3 million orthopedic procedures.
      Michael Barbella, Managing Editor 09.15.20

    • Research & Development
      Trends for Orthopedic Contract R&D and Manufacturing

      Trends for Orthopedic Contract R&D and Manufacturing

      Over the past 10 years, medtech manufacturers from startups to giants have grown their levels of outsourcing to contract R&D and manufacturing partners.
      Maria Shepherd, President and Founder, Medi-Vantage 09.15.20

    • Self-Care in Business: Four Ways to Extend the Peace of Home to the Workplace

      Self-Care in Business: Four Ways to Extend the Peace of Home to the Workplace

      Like so many small business owners, the lines between work and home often blur in the Lissy household.
      Dawn A. Lissy, Founder & President, Empirical 09.15.20


    Trending
    • FDA OKs Brainlab's Loop-X Mobile Imaging Robot, Cirq Robotic Alignment Module
    • NuVasive Nabs Simplify Medical For $150M
    • Mini MRI For Hand And Wrist Imaging Can Be Used Nearly Anywhere
    • Mini MRI for Hand and Wrist Imaging Can Be Used Nearly Anywhere
    • Orchid Appoints CCO
    Breaking News
    • Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    • Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    • First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    • NuVasive Nabs Simplify Medical for $150M
    • SeaSpine Begins Limited Launch of WaveForm TA (TLIF Articulating) 3D-Printed Interbody
    View Breaking News >
    CURRENT ISSUE

    January/February 2021

    • Instrumentation Innovations: A Review of Instrument Manufacturing
    • The Total Package: Packaging and Sterilization for Orthopedics
    • Helping Nature Take Its Course: A Biologics Breakdown
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet
    Refined Grains Linked to Heart Attack Risk, Early Death
    Kappa Bioscience Extends Research Partnership For COVID-19 Research
    Coatings World

    Latest Breaking News From Coatings World

    Nippon Paint Marine Wins Korea Export Award
    Universal Display Corporation, PPG Expand Global Production of UniversalPHOLED Materials
    PPG Introduces Premium Iso-free Primer Surfacer, Catalyst
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    January AI Raises $8.8 Million in New Funding
    FDA Clears Ava Fertility Tracking Wearable Device
    First Patient in Europe Treated With Diamondback 360 Coronary Orbital Atherectomy System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Spark Therapeutics Appoints CTO
    Cryoport Launches ESG Program
    U.S. Govt. Purchases 100k Doses of Lilly's COVID-19 Antibody Cocktail
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Top Beauty Products of 2021, According to HelloGiggles
    Estée Lauder Taps Ana de Armas as Global Brand Ambassador
    Sephora Announces Significant Expansion
    Happi

    Latest Breaking News From Happi

    Cosmetic Chemical Sales To Post CAGR 5.8% To 2025
    ACI Urges Senate to Approve Regan as EPA Administrator
    Estée Lauder Signs Actress Ana de Armas
    Ink World

    Latest Breaking News From Ink World

    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Marshall & Bruce Adds Koenig & Bauer Rapida 106 41-Inch Seven-Color Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FTA converts Forum & INFOFLEX to virtual events
    Xeikon launches two new digital label printing presses
    UFlex adds capacity in packaging films
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Texas Medical Technology Partners with My Protect Kit
    Mexico City Single-Use Plastics Ban Leads to Tampon Shortage
    Believe Diapers Launch in U.S.
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    First Implantation of CTL Amedica's Minimally Invasive Flex Tower
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login